Vanguard Group’s Radius Health, Inc. RDUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,317,485
| Closed | -$24M | – | 4641 |
|
|
2022
Q2 | $24M | Sell |
2,317,485
-1,323,281
| -36% | -$9.84M | ﹤0.01% | 2556 |
|
|
2022
Q1 | $32.1M | Sell |
3,640,766
-1,031,023
| -22% | -$7.82M | ﹤0.01% | 2535 |
|
|
2021
Q4 | $32.3M | Sell |
4,671,789
-126
| -0% | -$1.85K | ﹤0.01% | 2590 |
|
|
2021
Q3 | $58M | Buy |
4,671,915
+12,722
| +0.3% | +$183K | ﹤0.01% | 2286 |
|
|
2021
Q2 | $85M | Buy |
4,659,193
+1,917
| +0% | +$38.1K | ﹤0.01% | 2078 |
|
|
2021
Q1 | $97.2M | Buy |
4,657,276
+109,795
| +2% | +$2.31M | ﹤0.01% | 1960 |
|
|
2020
Q4 | $81.2M | Buy |
4,547,481
+213,376
| +5% | +$3.2M | ﹤0.01% | 1943 |
|
|
2020
Q3 | $49.1M | Sell |
4,334,105
-103,162
| -2% | -$1.27M | ﹤0.01% | 2024 |
|
|
2020
Q2 | $60.5M | Buy |
4,437,267
+120,974
| +3% | +$1.67M | ﹤0.01% | 1911 |
|
|
2020
Q1 | $56.1M | Buy |
4,316,293
+32,526
| +0.8% | +$580K | ﹤0.01% | 1819 |
|
|
2019
Q4 | $86.4M | Buy |
4,283,767
+23,543
| +0.6% | +$572K | ﹤0.01% | 1850 |
|
|
2019
Q3 | $110M | Buy |
4,260,224
+157,862
| +4% | +$3.87M | ﹤0.01% | 1668 |
|
|
2019
Q2 | $99.9M | Sell |
4,102,362
-6,009
| -0.1% | -$131K | ﹤0.01% | 1754 |
|
|
2019
Q1 | $81.9M | Buy |
4,108,371
+59,386
| +1% | +$1.08M | ﹤0.01% | 1845 |
|
|
2018
Q4 | $66.8M | Buy |
4,048,985
+477,414
| +13% | +$8.04M | ﹤0.01% | 1882 |
|
|
2018
Q3 | $63.6M | Buy |
3,571,571
+53,281
| +2% | +$1.21M | ﹤0.01% | 2032 |
|
|
2018
Q2 | $104M | Buy |
3,518,290
+152,183
| +5% | +$4.81M | ﹤0.01% | 1759 |
|
|
2018
Q1 | $121M | Buy |
3,366,107
+84,604
| +3% | +$3.06M | 0.01% | 1610 |
|
|
2017
Q4 | $104M | Buy |
3,281,503
+115,832
| +4% | +$3.63M | ﹤0.01% | 1690 |
|
|
2017
Q3 | $122M | Buy |
3,165,671
+19,954
| +0.6% | +$783K | 0.01% | 1599 |
|
|
2017
Q2 | $142M | Buy |
3,145,717
+135,071
| +4% | +$5.16M | 0.01% | 1466 |
|
|
2017
Q1 | $116M | Buy |
3,010,646
+93,188
| +3% | +$3.91M | 0.01% | 1571 |
|
|
2016
Q4 | $111M | Buy |
2,917,458
+219,324
| +8% | +$10.4M | 0.01% | 1557 |
|
|
2016
Q3 | $146M | Buy |
2,698,134
+82,966
| +3% | +$4.22M | 0.01% | 1328 |
|
|
2016
Q2 | $96.1M | Buy |
2,615,168
+311,547
| +14% | +$11M | 0.01% | 1539 |
|
|
2016
Q1 | $72.4M | Buy |
2,303,621
+39,974
| +2% | +$1.38M | ﹤0.01% | 1680 |
|
|
2015
Q4 | $139M | Buy |
2,263,647
+399,632
| +21% | +$25.2M | 0.01% | 1238 |
|
|
2015
Q3 | $129M | Buy |
1,864,015
+576,885
| +45% | +$40.1M | 0.01% | 1263 |
|
|
2015
Q2 | $87.1M | Buy |
1,287,130
+543,341
| +73% | +$25.3M | 0.01% | 1612 |
|
|
2015
Q1 | $30.6M | Buy |
743,789
+468,246
| +170% | +$21M | ﹤0.01% | 2151 |
|
|
2014
Q4 | $10.7M | Buy |
275,543
+226,071
| +457% | +$5.36M | ﹤0.01% | 2509 |
|
|
2014
Q3 | $1.04M | Buy |
+49,472
| New | +$668K | ﹤0.01% | 3495 |
|
Other funds holding RDUS
Vanguard Group's RDUS Position: Q3 2022 in Review
Vanguard Group sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 2,317,485 shares — an estimated $24M sold.
Vanguard Group first reported a position in RDUS in Q3 2014 and held it in 32 quarters. The position peaked at $146M in Q3 2016. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.
- Vanguard Group reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
- Vanguard Group sold 2,317,485 Radius Health, Inc. shares in Q3 2022, an estimated $24M.
- Vanguard Group first reported a position in Radius Health, Inc. in Q3 2014 and held it in 32 quarters.
- Vanguard Group's Radius Health, Inc. position peaked at $146M in Q3 2016.
- 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.
Based on Vanguard Group's 13F filing for Q3 2022, filed 14 Nov 2022.